<!DOCTYPE html>
<html lang="en">
<head id="Head1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="content-type" content="text/html;charset=utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Full Text of HB3489</title>
    <link rel="shortcut icon" type="image/x-icon" href="https://cdn.ilga.gov/assets/img/site/favicon.ico" />
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap.min.css" />
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <script src="https://cdn.ilga.gov/assets/js/fontawesome/fa.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/jquery.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/js.cookie.min.js"></script>
    <script async src="https://cse.google.com/cse.js?cx=a47f92b5e11c1499a"></script> 
    <!-- Bootstrap Datepicker CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap-datepicker.min.css">
    <!-- Bootstrap Datepicker JavaScript -->
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap-datepicker.min.js"></script>
    <!-- aos, bootstrap icons, swiper CSS -->
    <link href="https://cdn.ilga.gov/assets/css/aos/aos.css" rel="stylesheet">
    <link href="https://cdn.ilga.gov/assets/css/swiper/swiper-bundle.min.css" rel="stylesheet">

    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.js"></script>

    <!-- ILGA main CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/main.css" />
    <link rel="stylesheet" type="text/css" media="print" href="https://cdn.ilga.gov/assets/css/print.css">
    <style></style>
    
</head>
<body>
        <!-- ======= Header ======= -->
        <header id="print-header" class="d-flex align-items-center">
            <div class="container-fluid align-items-center text-uppercase justify-content-start ">
                <div class="logo ">
                    <a href="/"><img src="https://cdn.ilga.gov/assets/img/site/white_capitol.png" alt="ILGA Logo"><span>ILGA.GOV</span></a>
                </div>
                <div class="w-100"></div>
            </div>
        </header>
    <input id="TextSearch" type="hidden" />
    <input id="MobileTextSearch" type="hidden" />
    <input id="message-input" type="hidden" />

    <main id="main-content" role="main">
        <section class="main-page p-2">
	<div class="p-1 pt-4 float-left">
		<div class="row border-bottom pb-3 mb-3">
			<div class="text-start">
				<h2>
					HB3489 - 104th General Assembly
				</h2><br />
			</div>
		</div>
		<div id="content">
			<!-- Full text only shows on large screens -->
			<div class="centered-container d-lg-flex">
				<div class="left-aligned-content">
					<div class="row">
						<div class="col pl-lg-5" translate="no">
							<text class="ml-5 text-left fulltextLineHeight" id="billtextanchor">
								<style>
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p> </p><br> </td></tr></td></tr><tr><td class="number"></td><td class="junk"></td><td class="xsl"><table class="xsl" width="100%"><tr><td class="xsl"><center><b><pre><font size="3" face="Courier New">104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026</font><br>HB3489</pre></b></center><p> </p>Introduced 2/18/2025, by Rep. Michelle Mussman<p> </p><b>SYNOPSIS AS INTRODUCED:</b><br> </td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><table class="xsl" width="100%"><colgroup width="50%"></colgroup><colgroup width="50%"></colgroup><tr><td class="synopsis"><code>225 ILCS 85/3</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>225 ILCS 85/43</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>305 ILCS 5/5-5.12d</code></td><td class="synopsis"></td></tr></table><p></p></td></tr><tr><td class="xsl"><code>    </code><code>Amends the Pharmacy Practice Act. Provides that "practice of </code><code>pharmacy" includes the assessment and consultation of patients and </code><code>dispensing of contraceptives, including emergency contraception (rather </code><code>than the dispensation of hormonal contraceptives). In provisions </code><code>concerning the dispensation of contraceptives, changes the contraceptives </code><code>dispensed to contraceptives, including emergency contraception (rather </code><code>than hormonal contraceptives). Makes conforming changes. Amends the </code><code>Illinois Public Aid Code. Provides that the medical assistance program </code><code>shall cover patient care services provided by a pharmacist for </code><code>contraceptives, including emergency contraception (rather than hormonal </code><code>contraceptives). Makes conforming changes.</code></td></tr><tr align="right" class="lineNum"><td class="xsl"><br><br></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left"></td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><p> </p><p> </p><center><b>A BILL FOR</b></center><p></p></td></tr></table><p> </p></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>AN ACT concerning regulation.</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><b><code>Be it enacted by the People of the State of Illinois, </code></b></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><b><code>represented in the General Assembly:</code></b><br> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 5. </code><code>The Pharmacy Practice Act is amended by </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>changing Sections 3 and 43 as follows:</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(225 ILCS 85/3)</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(Section scheduled to be repealed on January 1, 2028)</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 3. </code><code>Definitions. </code><code>For the purpose of this Act, except </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>where otherwise limited therein:</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) "Pharmacy" or "drugstore" means and includes every </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>store, shop, pharmacy department, or other place where </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>pharmacist care is provided by a pharmacist (1) where drugs, </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>medicines, or poisons are dispensed, sold or offered for sale </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>at retail, or displayed for sale at retail; or (2) where </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>prescriptions of physicians, dentists, advanced practice </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>registered nurses, physician assistants, veterinarians, </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>podiatric physicians, or optometrists, within the limits of </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>their licenses, are compounded, filled, or dispensed; or (3) </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>which has upon it or displayed within it, or affixed to or used </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>in connection with it, a sign bearing the word or words </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>"Pharmacist", "Druggist", "Pharmacy", "Pharmaceutical Care", </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>"Apothecary", "Drugstore", "Medicine Store", "Prescriptions", </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>"Drugs", "Dispensary", "Medicines", or any word or words of </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>similar or like import, either in the English language or any </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>other language; or (4) where the characteristic prescription </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>sign (Rx) or similar design is exhibited; or (5) any store, or </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>shop, or other place with respect to which any of the above </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>words, objects, signs or designs are used in any </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>advertisement.</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) "Drugs" means and includes (1) articles recognized in </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>the official United States Pharmacopoeia/National Formulary </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>(USP/NF), or any supplement thereto and being intended for and </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>having for their main use the diagnosis, cure, mitigation, </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>treatment or prevention of disease in man or other animals, as </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>approved by the United States Food and Drug Administration, </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>but does not include devices or their components, parts, or </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>accessories; and (2) all other articles intended for and </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>having for their main use the diagnosis, cure, mitigation, </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>treatment or prevention of disease in man or other animals, as </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>approved by the United States Food and Drug Administration, </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>but does not include devices or their components, parts, or </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>accessories; and (3) articles (other than food) having for </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>their main use and intended to affect the structure or any </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>function of the body of man or other animals; and (4) articles </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>having for their main use and intended for use as a component </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>or any articles specified in clause (1), (2) or (3); but does </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>not include devices or their components, parts or accessories.</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) "Medicines" means and includes all drugs intended for </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>human or veterinary use approved by the United States Food and </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>Drug Administration.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) "Practice of pharmacy" means:</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) the interpretation and the provision of assistance </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>in the monitoring, evaluation, and implementation of </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>prescription drug orders; </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) the dispensing of prescription drug orders; </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) participation in drug and device selection; </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) drug administration limited to the administration </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>of oral, topical, injectable, and inhalation as follows: </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(A) in the context of patient education on the </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >        <code>proper use or delivery of medications; </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(B) vaccination of patients 7 years of age and </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >        <code>older pursuant to a valid prescription or standing </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >        <code>order, by a physician licensed to practice medicine in </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >        <code>all its branches, except for vaccinations covered by </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >        <code>paragraph (15), upon completion of appropriate </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >        <code>training, including how to address contraindications </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >        <code>and adverse reactions set forth by rule, with </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >        <code>notification to the patient's physician and </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >        <code>appropriate record retention, or pursuant to hospital </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >        <code>pharmacy and therapeutics committee policies and </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >        <code>procedures. Eligible vaccines are those listed on the </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >        <code>U.S. Centers for Disease Control and Prevention (CDC) </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >        <code>Recommended Immunization Schedule, the CDC's Health </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >        <code>Information for International Travel, or the U.S. Food </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >        <code>and Drug Administration's Vaccines Licensed and </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >        <code>Authorized for Use in the United States. As applicable </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >        <code>to the State's Medicaid program and other payers, </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >        <code>vaccines ordered and administered in accordance with </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >        <code>this subsection shall be covered and reimbursed at no </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >        <code>less than the rate that the vaccine is reimbursed when </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >        <code>ordered and administered by a physician; </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(B-5) (blank); </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(C) administration of injections of </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >        <code>alpha-hydroxyprogesterone caproate, pursuant to a </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >        <code>valid prescription, by a physician licensed to </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >        <code>practice medicine in all its branches, upon completion </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >        <code>of appropriate training, including how to address </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >        <code>contraindications and adverse reactions set forth by </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >        <code>rule, with notification to the patient's physician and </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >        <code>appropriate record retention, or pursuant to hospital </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >        <code>pharmacy and therapeutics committee policies and </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >        <code>procedures; and </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(D) administration of long-acting injectables for </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >        <code>mental health or substance use disorders pursuant to a </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >        <code>valid prescription by the patient's physician licensed </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >        <code>to practice medicine in all its branches, advanced </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >        <code>practice registered nurse, or physician assistant upon </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >        <code>completion of appropriate training conducted by an </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >        <code>Accreditation Council of Pharmaceutical Education </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >        <code>accredited provider, including how to address </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >        <code>contraindications and adverse reactions set forth by </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 5 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >        <code>rule, with notification to the patient's physician and </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >        <code>appropriate record retention, or pursuant to hospital </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >        <code>pharmacy and therapeutics committee policies and </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >        <code>procedures; </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) (blank); </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) drug regimen review; </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) drug or drug-related research; </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(8) the provision of patient counseling; </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(9) the practice of telepharmacy; </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(10) the provision of those acts or services necessary </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>to provide pharmacist care; </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(11) medication therapy management;</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(12) the responsibility for compounding and labeling </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>of drugs and devices (except labeling by a manufacturer, </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>repackager, or distributor of non-prescription drugs and </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>commercially packaged legend drugs and devices), proper </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>and safe storage of drugs and devices, and maintenance of </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>required records; </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(13) the assessment and consultation of patients and </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>dispensing of </code><strike><code>hormonal</code></strike><code> contraceptives</code><u><code>, including emergency </code></u></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <u><code>contraception</code></u><code>; </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(14) the initiation, dispensing, or administration of </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>drugs, laboratory tests, assessments, referrals, and </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>consultations for human immunodeficiency virus </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>pre-exposure prophylaxis and human immunodeficiency virus </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>post-exposure prophylaxis under Section 43.5;</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 6 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(15) vaccination of patients 7 years of age and older </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>for COVID-19 or influenza subcutaneously, intramuscularly, </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>or orally as authorized, approved, or licensed by the </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>United States Food and Drug Administration, pursuant to </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>the following conditions:</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(A) the vaccine must be authorized or licensed by </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >        <code>the United States Food and Drug Administration;</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(B) the vaccine must be ordered and administered </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >        <code>according to the Advisory Committee on Immunization </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >        <code>Practices standard immunization schedule;</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(C) the pharmacist must complete a course of </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >        <code>training accredited by the Accreditation Council on </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >        <code>Pharmacy Education or a similar health authority or </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >        <code>professional body approved by the Division of </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >        <code>Professional Regulation;</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(D) the pharmacist must have a current certificate </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >        <code>in basic cardiopulmonary resuscitation;</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(E) the pharmacist must complete, during each </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >        <code>State licensing period, a minimum of 2 hours of </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >        <code>immunization-related continuing pharmacy education </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >        <code>approved by the Accreditation Council on Pharmacy </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >        <code>Education;</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(F) the pharmacist must comply with recordkeeping </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >        <code>and reporting requirements of the jurisdiction in </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >        <code>which the pharmacist administers vaccines, including </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >        <code>informing the patient's primary-care provider, when </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 7 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >        <code>available, and complying with requirements whereby the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >        <code>person administering a vaccine must review the vaccine </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >        <code>registry or other vaccination records prior to </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >        <code>administering the vaccine; and</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(G) the pharmacist must inform the pharmacist's </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >        <code>patients who are less than 18 years old, as well as the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >        <code>adult caregiver accompanying the child, of the </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >        <code>importance of a well-child visit with a pediatrician </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >        <code>or other licensed primary-care provider and must refer </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >        <code>patients as appropriate;</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(16) the ordering and administration of COVID-19 </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>therapeutics subcutaneously, intramuscularly, or orally </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>with notification to the patient's physician and </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>appropriate record retention or pursuant to hospital </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>pharmacy and therapeutics committee policies and </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>procedures. Eligible therapeutics are those approved, </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>authorized, or licensed by the United States Food and Drug </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>Administration and must be administered subcutaneously, </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>intramuscularly, or orally in accordance with that </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>approval, authorization, or licensing; and</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(17) the ordering and administration of point of care </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>tests, screenings, and treatments for (i) influenza, (ii) </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>SARS-CoV-2, (iii) Group A Streptococcus, (iv) respiratory </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>syncytial virus, (v) adult-stage head louse, and (vi) </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>health conditions identified by a statewide public health </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>emergency, as defined in the Illinois Emergency Management </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 8 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>Agency Act, with notification to the patient's physician, </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>if any, and appropriate record retention or pursuant to </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>hospital pharmacy and therapeutics committee policies and </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>procedures. Eligible tests and screenings are those </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>approved, authorized, or licensed by the United States </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>Food and Drug Administration and must be administered in </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>accordance with that approval, authorization, or </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>licensing.</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>A pharmacist who orders or administers tests or </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>screenings for health conditions described in this </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>paragraph may use a test that may guide clinical </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>decision-making for the health condition that is waived </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>under the federal Clinical Laboratory Improvement </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>Amendments of 1988 and regulations promulgated thereunder </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>or any established screening procedure that is established </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>under a statewide protocol.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>A pharmacist may delegate the administrative and </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>technical tasks of performing a test for the health </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>conditions described in this paragraph to a registered </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>pharmacy technician or student pharmacist acting under the </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>supervision of the pharmacist. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>The testing, screening, and treatment ordered under </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>this paragraph by a pharmacist shall not be denied </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>reimbursement under health benefit plans that are within </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>the scope of the pharmacist's license and shall be covered </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>as if the services or procedures were performed by a </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 9 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>physician, an advanced practice registered nurse, or a </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>physician assistant.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>A pharmacy benefit manager, health carrier, health </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>benefit plan, or third-party payor shall not discriminate </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>against a pharmacy or a pharmacist with respect to </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>participation referral, reimbursement of a covered </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>service, or indemnification if a pharmacist is acting </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>within the scope of the pharmacist's license and the </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>pharmacy is operating in compliance with all applicable </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>laws and rules. </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>A pharmacist who performs any of the acts defined as the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>practice of pharmacy in this State must be actively licensed </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>as a pharmacist under this Act. </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e) "Prescription" means and includes any written, oral, </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>facsimile, or electronically transmitted order for drugs or </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>medical devices, issued by a physician licensed to practice </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>medicine in all its branches, dentist, veterinarian, podiatric </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>physician, or optometrist, within the limits of his or her </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>license, by a physician assistant in accordance with </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>subsection (f) of Section 4, or by an advanced practice </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>registered nurse in accordance with subsection (g) of Section </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>4, containing the following: (1) name of the patient; (2) date </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>when prescription was issued; (3) name and strength of drug or </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>description of the medical device prescribed; and (4) </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>quantity; (5) directions for use; (6) prescriber's name, </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>address, and signature; and (7) DEA registration number where </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 10 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>required, for controlled substances. The prescription may, but </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>is not required to, list the illness, disease, or condition </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>for which the drug or device is being prescribed. DEA </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>registration numbers shall not be required on inpatient drug </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>orders. A prescription for medication other than controlled </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>substances shall be valid for up to 15 months from the date </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>issued for the purpose of refills, unless the prescription </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>states otherwise. </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f) "Person" means and includes a natural person, </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>partnership, association, corporation, government entity, or </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>any other legal entity.</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(g) "Department" means the Department of Financial and </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>Professional Regulation.</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(h) "Board of Pharmacy" or "Board" means the State Board </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>of Pharmacy of the Department of Financial and Professional </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>Regulation.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(i) "Secretary" means the Secretary of Financial and </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>Professional Regulation.</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(j) "Drug product selection" means the interchange for a </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>prescribed pharmaceutical product in accordance with Section </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>25 of this Act and Section 3.14 of the Illinois Food, Drug and </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>Cosmetic Act.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(k) "Inpatient drug order" means an order issued by an </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>authorized prescriber for a resident or patient of a facility </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>licensed under the Nursing Home Care Act, the ID/DD Community </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>Care Act, the MC/DD Act, the Specialized Mental Health </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 11 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>Rehabilitation Act of 2013, the Hospital Licensing Act, or the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>University of Illinois Hospital Act, or a facility which is </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>operated by the Department of Human Services (as successor to </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>the Department of Mental Health and Developmental </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>Disabilities) or the Department of Corrections.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(k-5) "Pharmacist" means an individual health care </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>professional and provider currently licensed by this State to </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>engage in the practice of pharmacy.</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(l) "Pharmacist in charge" means the licensed pharmacist </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>whose name appears on a pharmacy license and who is </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>responsible for all aspects of the operation related to the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>practice of pharmacy.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(m) "Dispense" or "dispensing" means the interpretation, </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>evaluation, and implementation of a prescription drug order, </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>including the preparation and delivery of a drug or device to a </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>patient or patient's agent in a suitable container </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>appropriately labeled for subsequent administration to or use </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>by a patient in accordance with applicable State and federal </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>laws and regulations. "Dispense" or "dispensing" does not mean </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>the physical delivery to a patient or a patient's </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>representative in a home or institution by a designee of a </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>pharmacist or by common carrier. "Dispense" or "dispensing" </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>also does not mean the physical delivery of a drug or medical </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>device to a patient or patient's representative by a </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>pharmacist's designee within a pharmacy or drugstore while the </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>pharmacist is on duty and the pharmacy is open.</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 12 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(n) "Nonresident pharmacy" means a pharmacy that is </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>located in a state, commonwealth, or territory of the United </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>States, other than Illinois, that delivers, dispenses, or </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>distributes, through the United States Postal Service, </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>commercially acceptable parcel delivery service, or other </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>common carrier, to Illinois residents, any substance which </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>requires a prescription.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(o) "Compounding" means the preparation and mixing of </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>components, excluding flavorings, (1) as the result of a </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>prescriber's prescription drug order or initiative based on </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>the prescriber-patient-pharmacist relationship in the course </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>of professional practice or (2) for the purpose of, or </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>incident to, research, teaching, or chemical analysis and not </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>for sale or dispensing. "Compounding" includes the preparation </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>of drugs or devices in anticipation of receiving prescription </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>drug orders based on routine, regularly observed dispensing </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>patterns. Commercially available products may be compounded </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>for dispensing to individual patients only if all of the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>following conditions are met: (i) the commercial product is </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>not reasonably available from normal distribution channels in </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>a timely manner to meet the patient's needs and (ii) the </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>prescribing practitioner has requested that the drug be </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>compounded.</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(p) (Blank). </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(q) (Blank). </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(r) "Patient counseling" means the communication between a </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 13 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>pharmacist or a student pharmacist under the supervision of a </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>pharmacist and a patient or the patient's representative about </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>the patient's medication or device for the purpose of </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>optimizing proper use of prescription medications or devices. </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>"Patient counseling" may include without limitation (1) </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>obtaining a medication history; (2) acquiring a patient's </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>allergies and health conditions; (3) facilitation of the </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>patient's understanding of the intended use of the medication; </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>(4) proper directions for use; (5) significant potential </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>adverse events; (6) potential food-drug interactions; and (7) </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>the need to be compliant with the medication therapy. A </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>pharmacy technician may only participate in the following </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>aspects of patient counseling under the supervision of a </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>pharmacist: (1) obtaining medication history; (2) providing </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>the offer for counseling by a pharmacist or student </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>pharmacist; and (3) acquiring a patient's allergies and health </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>conditions. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(s) "Patient profiles" or "patient drug therapy record" </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>means the obtaining, recording, and maintenance of patient </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>prescription information, including prescriptions for </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>controlled substances, and personal information.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(t) (Blank). </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(u) "Medical device" or "device" means an instrument, </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>apparatus, implement, machine, contrivance, implant, in vitro </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>reagent, or other similar or related article, including any </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>component part or accessory, required under federal law to </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 14 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>bear the label "Caution: Federal law requires dispensing by or </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>on the order of a physician". A seller of goods and services </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>who, only for the purpose of retail sales, compounds, sells, </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>rents, or leases medical devices shall not, by reasons </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>thereof, be required to be a licensed pharmacy.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(v) "Unique identifier" means an electronic signature, </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>handwritten signature or initials, </code><u><code>thumbprint</code></u><code> </code><strike><code>thumb print</code></strike><code>, or </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>other acceptable biometric or electronic identification </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>process as approved by the Department.</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(w) "Current usual and customary retail price" means the </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>price that a pharmacy charges to a non-third-party payor. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(x) "Automated pharmacy system" means a mechanical system </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>located within the confines of the pharmacy or remote location </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>that performs operations or activities, other than compounding </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>or administration, relative to storage, packaging, dispensing, </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>or distribution of medication, and which collects, controls, </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>and maintains all transaction information.</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(y) "Drug regimen review" means and includes the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>evaluation of prescription drug orders and patient records for </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>(1) known allergies; (2) drug or potential therapy </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>contraindications; (3) reasonable dose, duration of use, and </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>route of administration, taking into consideration factors </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>such as age, gender, and contraindications; (4) reasonable </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>directions for use; (5) potential or actual adverse drug </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>reactions; (6) drug-drug interactions; (7) drug-food </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>interactions; (8) drug-disease contraindications; (9) </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 15 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>therapeutic duplication; (10) patient laboratory values when </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>authorized and available; (11) proper utilization (including </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>over or under utilization) and optimum therapeutic outcomes; </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>and (12) abuse and misuse. </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(z) "Electronically transmitted prescription" means a </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>prescription that is created, recorded, or stored by </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>electronic means; issued and validated with an electronic </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>signature; and transmitted by electronic means directly from </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>the prescriber to a pharmacy. An electronic prescription is </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>not an image of a physical prescription that is transferred by </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>electronic means from computer to computer, facsimile to </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>facsimile, or facsimile to computer. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(aa) "Medication therapy management services" means a </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>distinct service or group of services offered by licensed </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>pharmacists, physicians licensed to practice medicine in all </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>its branches, advanced practice registered nurses authorized </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>in a written agreement with a physician licensed to practice </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>medicine in all its branches, or physician assistants </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>authorized in guidelines by a supervising physician that </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>optimize therapeutic outcomes for individual patients through </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>improved medication use. In a retail or other non-hospital </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>pharmacy, medication therapy management services shall consist </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>of the evaluation of prescription drug orders and patient </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>medication records to resolve conflicts with the following:</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) known allergies;</code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) drug or potential therapy contraindications;</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 16 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) reasonable dose, duration of use, and route of </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>administration, taking into consideration factors such as </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>age, gender, and contraindications;</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) reasonable directions for use;</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) potential or actual adverse drug reactions;</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) drug-drug interactions;</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) drug-food interactions;</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(8) drug-disease contraindications;</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(9) identification of therapeutic duplication;</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(10) patient laboratory values when authorized and </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>available;</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(11) proper utilization (including over or under </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>utilization) and optimum therapeutic outcomes; and</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(12) drug abuse and misuse.</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Medication therapy management services" includes the </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>following:</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) documenting the services delivered and </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>communicating the information provided to patients' </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>prescribers within an appropriate time frame, not to </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>exceed 48 hours;</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) providing patient counseling designed to enhance a </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>patient's understanding and the appropriate use of his or </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>her medications; and</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) providing information, support services, and </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>resources designed to enhance a patient's adherence with </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>his or her prescribed therapeutic regimens.</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 17 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Medication therapy management services" may also include </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>patient care functions authorized by a physician licensed to </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>practice medicine in all its branches for his or her </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>identified patient or groups of patients under specified </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>conditions or limitations in a standing order from the </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>physician.</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Medication therapy management services" in a licensed </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>hospital may also include the following:</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) reviewing assessments of the patient's health </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>status; and</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) following protocols of a hospital pharmacy and </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>therapeutics committee with respect to the fulfillment of </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>medication orders. </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(bb) "Pharmacist care" means the provision by a pharmacist </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>of medication therapy management services, with or without the </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>dispensing of drugs or devices, intended to achieve outcomes </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>that improve patient health, quality of life, and comfort and </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>enhance patient safety. </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(cc) "Protected health information" means individually </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>identifiable health information that, except as otherwise </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>provided, is: </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) transmitted by electronic media;</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) maintained in any medium set forth in the </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>definition of "electronic media" in the federal Health </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>Insurance Portability and Accountability Act; or</code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) transmitted or maintained in any other form or </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 18 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>medium.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Protected health information" does not include </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>individually identifiable health information found in:</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) education records covered by the federal Family </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>Educational Right and Privacy Act; or</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) employment records held by a licensee in its role </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>as an employer.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(dd) "Standing order" means a specific order for a patient </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>or group of patients issued by a physician licensed to </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>practice medicine in all its branches in Illinois.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(ee) "Address of record" means the designated address </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>recorded by the Department in the applicant's application file </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>or licensee's license file maintained by the Department's </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>licensure maintenance unit.</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(ff) "Home pharmacy" means the location of a pharmacy's </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>primary operations. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(gg) "Email address of record" means the designated email </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>address recorded by the Department in the applicant's </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>application file or the licensee's license file, as maintained </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>by the Department's licensure maintenance unit. </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-16, eff. 6-17-21; 102-103, eff. 1-1-22; </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>102-558, eff. 8-20-21; 102-813, eff. 5-13-22; 102-1051, eff. </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>1-1-23; 103-1, eff. 4-27-23; 103-593, eff. 6-7-24; 103-612, </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>eff. 1-1-25; revised 11-26-24.)</code><br> </td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(225 ILCS 85/43)</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 19 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(Section scheduled to be repealed on January 1, 2028)</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 43. </code><code>Dispensation of </code><strike><code>hormonal</code></strike><code> contraceptives</code><u><code>, </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>including emergency contraception</code></u><code>.</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) The dispensing of </code><strike><code>hormonal</code></strike><code> contraceptives</code><u><code>, including </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><u><code>emergency contraception,</code></u><code> to a patient shall be pursuant to a </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>valid prescription, or pursuant to a standing order by a </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>physician licensed to practice medicine in all its branches, a </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>standing order by the medical director of a local health </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>department, or a standing order by the Department of Public </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>Health pursuant to the following:</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) a pharmacist may dispense no more than a 12-month </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>supply of </code><strike><code>hormonal</code></strike><code> contraceptives</code><u><code>, including emergency </code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <u><code>contraception,</code></u><code> to a patient;</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) a pharmacist must complete an educational training </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>program accredited by the Accreditation Council for </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>Pharmacy Education and approved by the Department that is </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>related to the patient self-screening risk assessment, </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>patient assessment contraceptive counseling and education, </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>and dispensation of </code><strike><code>hormonal</code></strike><code> contraceptives</code><u><code>, including </code></u></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <u><code>emergency contraception</code></u><code>;</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) a pharmacist shall have the patient complete the </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>self-screening risk assessment tool; the self-screening </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>risk assessment tool is to be based on the most current </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>version of the United States Medical Eligibility Criteria </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>for Contraceptive Use published by the federal Centers for </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>Disease Control and Prevention;</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 20 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) based upon the results of the self-screening risk </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>assessment and the patient assessment, the pharmacist </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>shall use his or her professional and clinical judgment as </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>to when a patient should be referred to the patient's </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>physician or another health care provider;</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) a pharmacist shall provide, during the patient </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>assessment and consultation, counseling and education </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>about all methods of contraception, including methods not </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>covered under the standing order, and their proper use and </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>effectiveness;</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) the patient consultation shall take place in a </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>private manner; and</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) a pharmacist and pharmacy must maintain </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>appropriate records.</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) The Department may adopt rules to implement this </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>Section.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) Nothing in this Section shall be interpreted to </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>require a pharmacist to dispense </code><strike><code>hormonal</code></strike><code> contraception</code><u><code>, </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><u><code>including emergency contraception,</code></u><code> under a standing order </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>issued by a physician licensed to practice medicine in all its </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>branches or the medical director of a local health department.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) Notwithstanding any other provision of the law to the </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>contrary, a pharmacist may dispense </code><strike><code>hormonal</code></strike><code> contraceptives</code><u><code>, </code></u></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><u><code>including emergency contraception,</code></u><code> in conformance with </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>standing orders issued pursuant to this Section without prior </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>establishment of a relationship between the pharmacist and the </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 21 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>person receiving </code><strike><code>hormonal</code></strike><code> contraception.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e) No employee of the Department of Public Health issuing </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>a standing order pursuant to this Section shall, as a result of </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>the employee's acts or omissions in issuing the standing order </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>pursuant to this Section, be subject to (i) any disciplinary </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>or other adverse action under the Medical Practice Act of </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>1987, (ii) any civil liability, or (iii) any criminal </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>liability. </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-103, eff. 1-1-22; 102-813, eff. 5-13-22; </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>102-1117, eff. 1-13-23.)</code><br> </td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 10. </code><code>The Illinois Public Aid Code is amended by </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>changing Section 5-5.12d as follows:</code><br> </td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(305 ILCS 5/5-5.12d)</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 5-5.12d. </code><code>Coverage for patient care services for </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><strike><code>hormonal</code></strike><code> contraceptives, human immunodeficiency virus </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>pre-exposure prophylaxis, and human immunodeficiency virus </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>post-exposure prophylaxis provided by a pharmacist.</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) Subject to approval by the federal Centers for </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>Medicare and Medicaid Services, the medical assistance </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>program, including both the fee-for-service and managed care </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>medical assistance programs established under this Article, </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>shall cover patient care services provided by a pharmacist for </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><strike><code>hormonal</code></strike><code> contraceptives</code><u><code>, including emergency contraception</code></u><code>, </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>human immunodeficiency virus pre-exposure prophylaxis, and </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 22 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>human immunodeficiency virus post-exposure prophylaxis </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>assessment and consultation.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) The Department shall establish a fee schedule for </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>patient care services provided by a pharmacist under Sections </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>43 and 43.5 of the Pharmacy Practice Act and shall be covered </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>and reimbursed at no less than 85% of the rate that the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>services are reimbursed when provided by a physician.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) The rate of reimbursement for patient care services </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>provided by a pharmacist for </code><strike><code>hormonal</code></strike><code> contraceptives</code><u><code>, </code></u></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><u><code>including emergency contraception</code></u><code>, human immunodeficiency </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>virus pre-exposure prophylaxis, and human immunodeficiency </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>virus post-exposure prophylaxis assessment and consultation </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>shall be at 85% of the fee schedule for physician services by </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>the medical assistance program.</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) A pharmacist must be enrolled in the medical </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>assistance program as an ordering and referring provider prior </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>to providing patient care services for </code><strike><code>hormonal</code></strike><code> </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>contraceptives</code><u><code>, including emergency contraception</code></u><code>, human </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>immunodeficiency virus pre-exposure prophylaxis, and human </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>immunodeficiency virus post-exposure prophylaxis assessment </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>and consultation that is submitted by a pharmacy or pharmacist </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>provider for reimbursement pursuant to this Section.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e) The Department shall apply for any necessary federal </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>waivers or approvals to implement this Section by January 1, </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>2023.</code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f) This Section does not restrict or prohibit any </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3489</td><td class="xsl" align="center">- 23 -</td><td class="xsl" align="right">LRB104 09911 AAS 19981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>services currently provided by pharmacists as authorized by </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>law, including, but not limited to, pharmacist services </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>provided under this Code or authorized under the Illinois </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>Title XIX State Plan.</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(g) The Department shall submit to the Joint Committee on </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>Administrative Rules administrative rules for this Section as </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>soon as practicable but no later than 6 months after federal </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>approval is received.</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-103, eff. 1-1-22; 102-813, eff. 5-13-22; </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>102-1051, eff. 1-1-23</code><code>.)</code></pre></table>
							</text>
						</div>
					</div>
				</div>
			</div>
		</div>
    </div>
</section>
    </main>
    <!-- Vendor JS Files -->
    <script src="https://cdn.ilga.gov/assets/js/aos/aos.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/popper.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap.bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/glightbox/glightbox.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/swiper/swiper-bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/main.js"></script>

    

</body>
</html>
